Abstract
This mini review describes human papillomavirus-related (pre)malignancies of the lower anogenital tract, for which female renal transplant recipients (RTRs) have a markedly increased risk. Until now, the implementation of intensified cervical cancer screening in RTRs is disappointing. We emphasize the need for improvement of cervical screening programs, combined with close inspection of the vulva and perianal area for potential lethal malignancies in RTRs.
MeSH terms
-
Anus Neoplasms / diagnosis
-
Anus Neoplasms / epidemiology
-
Anus Neoplasms / immunology*
-
Carcinoma, Squamous Cell / diagnosis
-
Carcinoma, Squamous Cell / epidemiology
-
Carcinoma, Squamous Cell / immunology*
-
Early Detection of Cancer*
-
Female
-
Genital Neoplasms, Female / diagnosis
-
Genital Neoplasms, Female / epidemiology
-
Genital Neoplasms, Female / immunology*
-
Human papillomavirus 16 / immunology
-
Human papillomavirus 18 / isolation & purification
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Kidney Transplantation / adverse effects*
-
Kidney Transplantation / immunology
-
Papillomavirus Infections / diagnosis
-
Papillomavirus Infections / epidemiology
-
Papillomavirus Infections / immunology*
-
Precancerous Conditions / diagnosis
-
Precancerous Conditions / epidemiology
-
Precancerous Conditions / immunology*
-
Uterine Cervical Neoplasms / diagnosis
-
Uterine Cervical Neoplasms / epidemiology
-
Uterine Cervical Neoplasms / immunology